Vimarsana
Biggest News Aggregation in the World

Nasdaq Plxp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Plxp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Plxp Today - Breaking & Trending Today

PLx Pharma (NASDAQ:PLXP) Stock Passes Above Fifty Day Moving Average of $0.00 - Vimarsana News

PLx Pharma (NASDAQ:PLXP) Stock Passes Above Fifty Day Moving Average of $0.00

PLx Pharma Inc. (NASDAQ:PLXP – Get Free Report)’s share price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. PLx Pharma shares last traded at $0.00, with a volume of 3,000 shares. PLx Pharma Price Performance […]

Financial Review: PLx Pharma (NASDAQ:PLXP) versus Amneal Pharmaceuticals (NYSE:AMRX) - Vimarsana News

Financial Review: PLx Pharma (NASDAQ:PLXP) versus Amneal Pharmaceuticals (NYSE:AMRX)

PLx Pharma (NASDAQ:PLXP – Get Rating) and Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership. Risk & Volatility PLx Pharma has a beta of […]

PLx Pharma (NASDAQ:PLXP) Stock Price Crosses Below 200 Day Moving Average of $0.36 - Vimarsana News

PLx Pharma (NASDAQ:PLXP) Stock Price Crosses Below 200 Day Moving Average of $0.36

PLx Pharma Inc. (NASDAQ:PLXP – Get Rating) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.36 and traded as low as $0.12. PLx Pharma shares last traded at $0.14, with a volume of 291,552 shares trading hands. PLx Pharma Price Performance The company’s […]

Survey: Cardiovascular Patients on Aspirin Therapy Prefer - Vimarsana News

Survey: Cardiovascular Patients on Aspirin Therapy Prefer

Results of National Patient Experience Survey Show 95% Satisfaction Rate with VAZALORE 81 mg as Aspirin Therapy Choice FDA-Approved VAZALORE...

PLx Pharma (NASDAQ:PLXP) Stock Passes Above 50-Day Moving Average of $2.31 - Vimarsana News

PLx Pharma (NASDAQ:PLXP) Stock Passes Above 50-Day Moving Average of $2.31

PLx Pharma Inc. (NASDAQ:PLXP – Get Rating)’s share price crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $2.31 and traded as high as $2.36. PLx Pharma shares last traded at $2.36, with a volume of 171,660 shares traded. PLx Pharma Stock Up […]